cGMP Dependent Kinase Inhibitor Peptide acetate

Produktübersicht

• Artikelname: cGMP Dependent Kinase Inhibitor Peptide acetate
• Artikelnummer: TGM-TP1903L1
• Hersteller Artikelnummer: TP1903L1
• Alternativnummer: TGM-TP1903L1-5MG, TGM-TP1903L1-10MG, TGM-TP1903L1-25MG, TGM-TP1903L1-50MG, TGM-TP1903L1-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

cGMP Dependent Kinase Inhibitor Peptide acetate is a highly selective, ATP-competitive inhibitor of cGMP-dependent protein kinase (PKG/cGKI). cGMP Dependent Kinase Inhibitor Peptide acetate is a synthetically produced peptide with a Ki value of 86 µM. cGMP Dependent Kinase Inhibitor Peptide acetate inhibits PKG-dependent myosin light chain phosphorylation in vascular smooth muscle cells, blocking vasodilatory signaling, and is used in cardiovascular disease research. cGMP Dependent Kinase Inhibitor Peptide acetate also inhibits PfPKG in Plasmodium and Toxoplasma, and is used in antiparasitic research.

Produkteigenschaften

• Molekulargewicht: 1003.16
• Reinheit: 97.87%
• Formel: C40H78N18O12
• Target-Kategorie: PKA

Bilder

TP1903L1